Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) went up by 14.92% from its latest closing price compared to the recent 1-year high of $2.07. The company’s stock price has collected 8.82% of gains in the last five trading sessions.
Is It Worth Investing in Sonnet BioTherapeutics Holdings Inc. (NASDAQ :SONN) Right Now?
Plus, the 36-month beta value for SONN is at 0.66. Opinions of the stock are interesting as 2 analysts out of 2 who provided ratings for Sonnet BioTherapeutics Holdings Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $2.25, which is $1.97 above the current price. SONN currently public float of 58.45M and currently shorts hold a 1.64% ratio of that float. Today, the average trading volume of SONN was 3.15M shares.
SONN’s Market Performance
SONN stocks went up by 8.82% for the week, with a monthly jump of 6.55% and a quarterly performance of -38.89%, while its annual performance rate touched -81.67%. The volatility ratio for the week stands at 9.78% while the volatility levels for the past 30 days are set at 8.35% for Sonnet BioTherapeutics Holdings Inc. The simple moving average for the period of the last 20 days is 8.79% for SONN stocks with a simple moving average of -36.79% for the last 200 days.
SONN Trading at -4.28% from the 50-Day Moving Average
After a stumble in the market that brought SONN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -86.71% of loss for the given period.
Volatility was left at 8.35%, however, over the last 30 days, the volatility rate increased by 9.78%, as shares surge +5.77% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -29.85% lower at present.
During the last 5 trading sessions, SONN rose by +8.82%, which changed the moving average for the period of 200-days by -57.16% in comparison to the 20-day moving average, which settled at $0.2535. In addition, Sonnet BioTherapeutics Holdings Inc. saw -33.43% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for SONN
Current profitability levels for the company are sitting at:
- -5187.36 for the present operating margin
The net margin for Sonnet BioTherapeutics Holdings Inc. stands at -5165.97. Equity return is now at value -226.40, with -152.70 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 4.30.